{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:39:37Z","timestamp":1792273177995,"version":"4.4.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.nano.2016.12.021","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T13:17:46Z","timestamp":1483708666000},"page":"1147-1155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Potential of CeCl 3 @mSiO 2 nanoparticles in alleviating diabetic cataract development and progression"],"prefix":"10.1016","volume":"13","author":[{"given":"Jin","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqun","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2016.12.021_bb0005","doi-asserted-by":"crossref","first-page":"608751","DOI":"10.1155\/2010\/608751","article-title":"Diabetic cataract-pathogenesis, epidemiology and treatment","volume":"2010","author":"Pollreisz","year":"2010","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.nano.2016.12.021_bb0010","first-page":"52","article-title":"Cataracts in diabetic patients: a review article","volume":"3","author":"Javadi","year":"2008","journal-title":"J Ophthalmic Vis Res"},{"key":"10.1016\/j.nano.2016.12.021_bb0015","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/dmrr.1075","article-title":"Diabetic cataracts: mechanisms and management \u2020","volume":"26","author":"Obrosova","year":"2010","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.nano.2016.12.021_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.nano.2016.12.021_bb0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/ICU.0b013e328333e9c1","article-title":"Cataract surgery and diabetes","volume":"21","author":"Shah","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.nano.2016.12.021_bb0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/00055735-200106000-00005","article-title":"Cataract surgery in diabetes","volume":"12","author":"Dowler","year":"2001","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.nano.2016.12.021_bb0035","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2174\/187152512802651097","article-title":"Aldose reductase, oxidative stress and diabetic cardiovascular complications","volume":"10","author":"Vedantham","year":"2012","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/j.nano.2016.12.021_bb0040","first-page":"713","article-title":"Mechanisms initiating cataract formation. Proctor lecture","volume":"13","author":"Kinoshita","year":"1974","journal-title":"Investig Ophthalmol"},{"key":"10.1016\/j.nano.2016.12.021_bb0045","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1196\/annals.1338.066","article-title":"The maillard reaction in eye diseases","volume":"1043","author":"Stitt","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.nano.2016.12.021_bb0050","doi-asserted-by":"crossref","first-page":"18505","DOI":"10.1016\/S0021-9258(19)36991-1","article-title":"Site-specific and random fragmentation of Cu, Zn-superoxide dismutase by glycation reaction implication of reactive oxygen species","volume":"267","author":"Ookawara","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.nano.2016.12.021_bb0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0161-6420(99)00024-X","article-title":"Diet and cataract \u2606: the blue mountains eye study","volume":"107","author":"Cumming","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.nano.2016.12.021_bb0060","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0378-5173(90)90201-E","article-title":"Oxygen radical scavenging activity of curcumin","volume":"58","author":"Kunchandy","year":"1990","journal-title":"Int J Pharm"},{"key":"10.1016\/j.nano.2016.12.021_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3109\/10715762.2013.777155","article-title":"Antioxidants and cataract","volume":"47","author":"Thiagarajan","year":"2013","journal-title":"Free Radic Res"},{"key":"10.1016\/j.nano.2016.12.021_bb0070","article-title":"Aldose reductase inhibitors as potential therapeutic drugs of diabetic complications","volume":"18","author":"Zhu","year":"2013","journal-title":"Chin J New Drugs"},{"key":"10.1016\/j.nano.2016.12.021_bb0075","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4103\/0974-9233.106384","article-title":"Nanotechnology approaches for ocular drug delivery","volume":"20","author":"Xu","year":"2013","journal-title":"Middle East Afr J Ophthalmol"},{"key":"10.1016\/j.nano.2016.12.021_bb0080","doi-asserted-by":"crossref","first-page":"e78217","DOI":"10.1371\/journal.pone.0078217","article-title":"Efficacy of biodegradable curcumin nanoparticles in delaying cataract in diabetic rat model","volume":"8","author":"Grama","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2016.12.021_bb0085","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/s12272-013-0195-2","article-title":"Silica-based cerium (III) chloride nanoparticles prevent the fructose-induced glycation of \u03b1-crystallin and H2O 2-induced oxidative stress in human lens epithelial cells","volume":"37","author":"Yang","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.nano.2016.12.021_bb0090","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1158\/1538-7445.AM2014-4459","article-title":"Characterization of a novel magnetic nanoparticles formulation for cancer therapeutic applications","volume":"74","author":"Yallapu","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.nano.2016.12.021_bb0095","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1167\/iovs.04-1304","article-title":"Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats","volume":"46","author":"Suryanarayana","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.nano.2016.12.021_bb0100","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/jaoac\/92.1.50","article-title":"Factors affecting accuracy and time requirements of a glucose oxidase-peroxidase assay for determination of glucose","volume":"92","author":"Hall","year":"2009","journal-title":"J AOAC Int"},{"key":"10.1016\/j.nano.2016.12.021_bb0105","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1073\/pnas.95.9.4882","article-title":"Protein-bound acrolein: potential markers for oxidative stress","volume":"95","author":"Uchida","year":"1998","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.nano.2016.12.021_bb0110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1432-1033.1974.tb03714.x","article-title":"Involvement of the superoxide anion radical in the autoxidation of Pyrogallol and a convenient assay for superoxide dismutase","volume":"47","author":"Marklund","year":"1974","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.nano.2016.12.021_bb0115","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-4835(83)90085-4","article-title":"Superoxide dismutase, catalase and glutathione peroxidase in the human cataractous lens \u2606","volume":"36","author":"Fecondo","year":"1983","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.nano.2016.12.021_bb0120","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2165\/00126839-200405030-00001","article-title":"Lipid peroxidation and cataracts: N-acetylcarnosine as a therapeutic tool to manage age-related cataracts in human and in canine eyes","volume":"5","author":"Babizhayev","year":"2004","journal-title":"Drugs R D"},{"key":"10.1016\/j.nano.2016.12.021_bb0125","first-page":"978","article-title":"Lipid peroxidation and the total antioxidant status in the pathogenesis of age related and diabetic cataracts: a study on the lens and blood","volume":"7","author":"Katta","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/j.nano.2016.12.021_bb0130","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0886-3350(02)01841-2","article-title":"Increased levels of advanced glycation end products in human cataractous lenses","volume":"29","author":"Franke","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"10.1016\/j.nano.2016.12.021_bb0135","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbrc.2010.01.095","article-title":"Citric acid inhibits development of cataracts, proteinuria and ketosis in streptozotocin (type 1) diabetic rats","volume":"393","author":"Nagai","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.nano.2016.12.021_bb0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.nano.2014.09.014","article-title":"Mesoporous silica nanoparticles in drug delivery and biomedical applications","volume":"11","author":"Wang","year":"2015","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2016.12.021_bb0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2217\/nnm.15.212","article-title":"Mesoporous silica nanoparticles in tissue engineering--a perspective","volume":"11","author":"Rosenholm","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.nano.2016.12.021_bb0150","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbrc.2014.03.012","article-title":"Effect of chronic hyperglycemia on crystallin levels in rat lens","volume":"446","author":"Reddy","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"issue":"Suppl. 1","key":"10.1016\/j.nano.2016.12.021_bb0155","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1007\/BF02343078","article-title":"Crystallin composition of human cataractous lens may be modulated by protein glycation","volume":"234","author":"Ramalho","year":"1996","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.nano.2016.12.021_bb0160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10741-013-9374-y","article-title":"Advanced glycation end products: role in pathology of diabetic cardiomyopathy","volume":"19","author":"Bodiga","year":"2014","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.nano.2016.12.021_bb0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/ICU.0b013e32801129fc","article-title":"The management of diabetic eye disease in the setting of cataract surgery","volume":"18","author":"Murtha","year":"2007","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.nano.2016.12.021_bb0170","doi-asserted-by":"crossref","first-page":"144 e2","DOI":"10.1016\/j.ajo.2010.03.019","article-title":"Nanomedicine in ophthalmology: the new frontier","volume":"150","author":"Zarbin","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.nano.2016.12.021_bb0175","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1089\/cbr.2006.21.520","article-title":"Lanthanide-loaded liposomes for multimodality imaging and therapy","volume":"21","author":"Zielhuis","year":"2006","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.nano.2016.12.021_bb0180","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1098\/rstb.2010.0300","article-title":"The ageing lens and cataract: a model of normal and pathological ageing","volume":"366","author":"Michael","year":"2011","journal-title":"Philos Trans R Soc Lond Ser B Biol Sci"},{"key":"10.1016\/j.nano.2016.12.021_bb0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jdiacomp.2012.09.005","article-title":"Xanthine oxidase and lens oxidative stress markers in diabetic and senile cataract patients","volume":"27","author":"Miric","year":"2013","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.nano.2016.12.021_bb0190","article-title":"Antioxidant cerium oxide nanoparticles in biology and medicine","volume":"5","author":"Nelson","year":"2016","journal-title":"Antioxidants (Basel)"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963416302386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963416302386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T18:14:31Z","timestamp":1658340871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963416302386"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1549963416302386"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2016.12.021","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of CeCl3@mSiO2 nanoparticles in alleviating diabetic cataract development and progression","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2016.12.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}